All companies
Visit website
Jogo Health
OperatingJogoHealth, Inc.
Founded 2010
Stroke, chronic pain & incontinence treatment via telehealth with wearables & AI
Post-money valuation ⓘ
$37.0M
As of Apr 2024 · from JOGO HEALTH Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$2,301,695
Across 3 rounds since 2021
Latest share price
$1.1262
Reg CF Offering (2025) offering price
Financials
FY2019–FY2024 · from SEC filings · hover any figure for its source$7K
−$383K
2019
$0
−$925K
2020
$167K
−$1.7M
2021
$251K
−$2.8M
2022
$253K
−$1.6M
2023
$274K
−$2.5M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$7,034
$0
$166,519
$250,884
$253,476
$274,267
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
100%
—
100%
100%
100%
100%
Net income
-$382,846
-$924,976
-$1,669,416
-$2,837,334
-$1,630,915
-$2,529,678
Taxes paid
$51,687
$113,620
$0
$0
$0
$0
Balance sheet
Cash
$1,665,674
$786,071
$2,834,773
$1,292,455
$1,259,998
$2,447,570
Accounts receivable
$0
$0
$5,898
$23,925
$3,894
$21,205
Total assets
$1,937,524
$1,183,537
$3,425,047
$1,730,461
$2,877,524
$5,605,609
Short-term debt
$0
$33,594
$346
$2,869
$2,581,637
$296,795
Long-term debt
$0
$0
$4,002,167
$5,137,168
$3,066,606
$100,157
Total liabilities
$0
$33,594
$4,002,513
$5,140,037
$5,648,243
$396,952
Other
Headcount
—
50
—
80
2
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$20.0M
Valuation cap
$37.0M
post-money
JOGO Health Convertible Note 1
JOGO HEALTH Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $500K
Raised — / $3MPost-money $37M
Raised $2.3M / $3.5MInvestors
Reg CF annual-report compliance
Delinquent
Filed 2 of 5 annual reports (FY2021–FY2025)
Missing: 2021, 2023, 2025
487 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 14 filings on EDGARSource: ManualCIK 0001777982Share price $1.1262
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.